YC 170

calcium channel activator; structure given in first source

Also Known As:

YC-170; 3-Pyridinecarboxylic acid, 4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethyl-5-((phenylamino)carbonyl)-, 2-(2-pyridinyl)ethyl ester

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ischemia 07/01/1987 - "Using an experimental model of global ischemia of the brain in rats, we have shown that a Ca2+ antagonist nicardipine attenuates, and a Ca2+ agonist YC-170 accelerates, the liberation of free fatty acids in the ischemic whole brain. "

1.	Nicardipine (Dagan)
2.	Nonesterified Fatty Acids (NEFA)